A takeover was not in the near future. Jack was in way over his head in leading a company forward, glad the BOD acted, however, a tad late in the game but nonetheless in enough time to react. Eisai needs to go and a leader hopefully will force them out for not fullfilling their end of the deal. No ads, reduced sales force, no movement in other markets in other countries, EU delay's and overall poor mgt of the product.
Must have been very informative. It was trading at 2.83 at 11 AM and we're trading where? Guess they didn't like the answers to the questions whatever those ghost questions were.
Why are you reposting a yahoo headline? Do you think people go to the message boards just to see what you post? Maybe you and Tang are 1 in the same.
This bank was yelling sell at 18!!!! Now its 20. They're a little too late to the party.
Beat the street by .03, at a burn rate of 27M per Qtr that gives us 2 years without need of further funding. Should be ample time to move the pipe and doesn't include any rises in revenues which we should see going forward. Now if Jack would be so kind to step down, kick our worthless partner to the curb, involve a real BP to move B along with other indications and territories and we should be just fine.
Good luck with that thought. Last time I checked, 2 of his other shorts were down .3%, qcom + intc not the +7% drubbing here. Navellier has swks as 1 of his top 5 picks, every analyst has their opinions. I bought on Louis's pick unfortunately after today that just went red. He also picked qrvo and in his last weekly was touting how well his picks were doing, guess he's not watching day to day events.
Not buying it. RAI is up with lower yield, higher P/E current + forward. MO on the lower end of yield BUT the divvy increase will be announced in Aug as usual. Stock buyback added again. This is now grossly oversold when compared to its peer RAI, plus, MO has what RAI doesn't have, revenues outside tobacco in SAB. The asset value of that investment could eliminate the entire debt in MO.
It's all about guidance in the short term. Look at BWLD + PNRA, both missed top and bottom line, both surged on guidance. Would I buy either 1, no. Valuations are too high for projected growth. Some concern here as beyond the next QTR they didn't really give any meaningful color on the outlook going forward and how long the slowdown will last.
They lowered guidance 14% and the stock is down, 14%. What do you expect. I bought based on that idiot Navellier's rec to buy below 86, luckily I bought well under that but still lost a bunch today. That was horrible guidance.
Take the Piper view with a grain of salt, remember, they were the architect and beneficiary of the last stock secondary and want to maintain that relationship as ARNA will need another one. The pipe is strong but it takes bucks to move it forward and unfortunately, our worthless partner isn't helping with reduced ads and salespeople. That hook up was the worst we have done and the cause of why B hasn't moved. The other indications particularly smoking cessation is huge but E doesn't have the capital to move it, along with getting other countries to approve the drug. The hype has already fizzled and we've already given back all those gains. Bought this long ago pre-approval and wasn't expecting much and knew it was a multi-year story, just a tad irate about our lousy partner E and their lack of engagement.
Let me guess, after you shorted at the high of the day, great move, you covered today at 19.62 the low of the day right? I'm pretty good at picking stocks after the fact too.
Very astute analysis, you sound like a sharp investor who knows his stuff. Being that elite investor you are, why wait, short the stock here and/or buy in the money puts.
One part is not true, this was printed 4/13/15
Jefferies recommends buying the following 10 potential M&A targets:
1. Arena Pharmaceuticals, Inc.
2. Lexicon Pharmaceuticals, Inc.
3. Seattle Genetics, Inc.
4. Sangamo Biosciences, Inc.
5. DHT Holdings Inc
6. BioScrip Inc
7. OraSure Technologies, Inc.
8. Sonus Networks, Inc.
9. NuVasive, Inc.
10. Allscripts Healthcare Solutions Inc
The stock is down over 21% since 4/9. Based on all the other casino stocks expect another 5 - 10% decline tomorrow when they miss and they will miss. The positive is the same as the negative, the opening of the new casino. The positive is the open and at least the expected number of tables. The negative, the open with below or no gaming tables. Macau is going to shoot themselves in the foot with all their constraints, ie smoking bans, table allocations, reduced number of tourists. In a perverse way I hope they adopt everything and everyone stops going and the country plunges into a depression. Bottom line, don't buy here but wait till that decision is made. Keeping my shares as they are well under water but miracles do happen.
Only issue I heard was the length of the studies, not looking for anything until the earliest 2017 for possible approval. Cash on hand to cover +20 months and any milestone payments will extend that and there will be some.
Placed an order to buy at 5.50, watched it drop to 5.51 expecting to buy and it went up and never covered.
I agree she's clueless, HOWEVER, the call was to sell into the strength on Fri and in 2 trading days we're down 9%